AngioDynamics Inc (ANGO)

Currency in USD
11.77
+0.54(+4.81%)
Real-time Data·

ANGO Earnings

Latest Release
Oct 08, 2026
EPS / Forecast
-0.04 / -0.11
Revenue / Forecast
80.9M / 80.5M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/11--/-0.083--/83.98M----Free Sign Up
2026/08-0.040/-0.11080.90M/80.50M+63.64%+0.5%Free Sign Up
2026/05-0.070/-0.09086.61M/80.24M+22.22%+7.94%Free Sign Up
2026/02-0.070/-0.09078.42M/76.71M+22.22%+2.23%Free Sign Up
2025/110.000/-0.10079.40M/76.30M+100%+4.06%Free Sign Up
2025/08-0.260/-0.12075.71M/72.70M-116.67%+4.14%Free Sign Up
2025/05-0.030/-0.12080.20M/74.27M+75%+7.98%Free Sign Up
2025/02-0.110/-0.11072.00M/70.57M0%+2.03%Free Sign Up
2024/11-0.040/-0.11073.00M/70.93M+63.64%+2.92%Free Sign Up
2024/08-0.110/-0.16067.50M/69.00M+31.25%-2.17%Free Sign Up

All numbers in USD

AngioDynamics Inc Earnings Call Summary for Q1/2027

  • AngioDynamics posted Q1 FY2027 adjusted loss of $0.04/share, beating estimates of $0.11 loss; revenue rose 6.9% to $80.9M vs. $80.5M forecast.
  • Gross margin expanded 410bps to 59.4% driven by product mix and tariff refunds; Med Tech revenue grew 13.2% to $39.9M, nearing 49% of total sales.
  • Company maintained FY2027 guidance: revenue $336-341M (5-6.5% growth), Med Tech growth 12-15%, adjusted EBITDA $13-16M, positive operating cash flow.
  • Shares fell 2.96% premarket to $13.77 despite earnings beat, as investors weighed modest revenue growth and continued Q1 cash outflow concerns.
  • CEO Clemmer highlighted 21 consecutive quarters of double-digit growth in key products; analysts remain optimistic with price targets of $17-24.
Last Updated: 2026-10-08, 08:52 a/m
Read Full Transcript

FAQ

What Is AngioDynamics's Earnings Per Share (TTM)?

The AngioDynamics EPS (TTM) is -0.79.

When Is The Next AngioDynamics Earnings Date?

AngioDynamics will release its next earnings report on Jan 07, 2027.

What Is AngioDynamics’s Revenue Forecasts For Upcoming Quarters?

AngioDynamics’s revenue forecast is 83.98M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.